These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23638404)

  • 1. Virtual screening for oseltamivir-resistant a (H5N1) influenza neuraminidase from traditional Chinese medicine database: a combined molecular docking with molecular dynamics approach.
    Karthick V; Ramanathan K
    Springerplus; 2013 Dec; 2(1):115. PubMed ID: 23638404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of potential inhibitors of H5N1 influenza A virus neuraminidase by ligand-based virtual screening approach.
    Karthick V; Ramanathan K; Shanthi V; Rajasekaran R
    Cell Biochem Biophys; 2013 Jul; 66(3):657-69. PubMed ID: 23306969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inhibitory performance of flavonoid cyanidin-3-sambubiocide against H274Y mutation in H1N1 influenza virus.
    Kannan S; Kolandaivel P
    J Biomol Struct Dyn; 2018 Dec; 36(16):4255-4269. PubMed ID: 29199545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Competitive fitness of oseltamivir-sensitive and -resistant highly pathogenic H5N1 influenza viruses in a ferret model.
    Govorkova EA; Ilyushina NA; Marathe BM; McClaren JL; Webster RG
    J Virol; 2010 Aug; 84(16):8042-50. PubMed ID: 20519385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of Potent Neuraminidase Inhibitors Using a Combination of Pharmacophore-Based Virtual Screening and Molecular Simulation Approach.
    K R; V S
    Appl Biochem Biotechnol; 2018 Apr; 184(4):1421-1440. PubMed ID: 29063410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insight into the oseltamivir resistance R292K mutation in H5N1 influenza virus: a molecular docking and molecular dynamics approach.
    Karthick V; Ramanathan K
    Cell Biochem Biophys; 2014 Mar; 68(2):291-9. PubMed ID: 23794010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational studies of H5N1 influenza virus resistance to oseltamivir.
    Wang NX; Zheng JJ
    Protein Sci; 2009 Apr; 18(4):707-15. PubMed ID: 19309695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacophore-Based Virtual Screening for Identification of Novel Neuraminidase Inhibitors and Verification of Inhibitory Activity by Molecular Docking.
    Batool S; Mushtaq G; Kamal W; Kamal MA
    Med Chem; 2016; 12(1):63-73. PubMed ID: 26152143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Source of oseltamivir resistance due to single E119D and double E119D/H274Y mutations in pdm09H1N1 influenza neuraminidase.
    Hanpaibool C; Leelawiwat M; Takahashi K; Rungrotmongkol T
    J Comput Aided Mol Des; 2020 Jan; 34(1):27-37. PubMed ID: 31773463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding pattern of the long acting neuraminidase inhibitor laninamivir towards influenza A subtypes H5N1 and pandemic H1N1.
    Meeprasert A; Khuntawee W; Kamlungsua K; Nunthaboot N; Rungrotmongkol T; Hannongbua S
    J Mol Graph Model; 2012 Sep; 38():148-54. PubMed ID: 23079644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel N-Substituted oseltamivir derivatives as potent influenza neuraminidase inhibitors: Design, synthesis, biological evaluation, ADME prediction and molecular docking studies.
    Ye J; Yang X; Xu M; Chan PK; Ma C
    Eur J Med Chem; 2019 Nov; 182():111635. PubMed ID: 31493744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of potential drugs for human-infecting H7N9 virus containing R294K mutation.
    He JY; Li C; Wu G
    Drug Des Devel Ther; 2014; 8():2377-90. PubMed ID: 25489236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Source of oseltamivir resistance in avian influenza H5N1 virus with the H274Y mutation.
    Malaisree M; Rungrotmongkol T; Nunthaboot N; Aruksakunwong O; Intharathep P; Decha P; Sompornpisut P; Hannongbua S
    Amino Acids; 2009 Oct; 37(4):725-32. PubMed ID: 19002747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-Based Optimization of N-Substituted Oseltamivir Derivatives as Potent Anti-Influenza A Virus Agents with Significantly Improved Potency against Oseltamivir-Resistant N1-H274Y Variant.
    Zhang J; Murugan NA; Tian Y; Bertagnin C; Fang Z; Kang D; Kong X; Jia H; Sun Z; Jia R; Gao P; Poongavanam V; Loregian A; Xu W; Ma X; Ding X; Huang B; Zhan P; Liu X
    J Med Chem; 2018 Nov; 61(22):9976-9999. PubMed ID: 30365885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the cause of oseltamivir resistance against mutant H274Y neuraminidase by molecular simulation approach.
    Karthick V; Shanthi V; Rajasekaran R; Ramanathan K
    Appl Biochem Biotechnol; 2012 May; 167(2):237-49. PubMed ID: 22544690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of the new neuraminidase inhibitor CS-8958 against H5N1 influenza viruses.
    Kiso M; Kubo S; Ozawa M; Le QM; Nidom CA; Yamashita M; Kawaoka Y
    PLoS Pathog; 2010 Feb; 6(2):e1000786. PubMed ID: 20195462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular dynamics simulation of oseltamivir resistance in neuraminidase of avian influenza H5N1 virus.
    Shu M; Lin Z; Zhang Y; Wu Y; Mei H; Jiang Y
    J Mol Model; 2011 Mar; 17(3):587-92. PubMed ID: 20517627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theoretical studies on the susceptibility of oseltamivir against variants of 2009 A/H1N1 influenza neuraminidase.
    Li L; Li Y; Zhang L; Hou T
    J Chem Inf Model; 2012 Oct; 52(10):2715-29. PubMed ID: 22998323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of neuraminidase inhibitor-resistant mutations on pathogenicity of clade 2.2 A/Turkey/15/06 (H5N1) influenza virus in ferrets.
    Ilyushina NA; Seiler JP; Rehg JE; Webster RG; Govorkova EA
    PLoS Pathog; 2010 May; 6(5):e1000933. PubMed ID: 20523902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanism of the enhanced viral fitness contributed by secondary mutations in the hemagglutinin protein of oseltamivir resistant H1N1 influenza viruses: modeling studies of antibody and receptor binding.
    Behera AK; Basu S; Cherian SS
    Gene; 2015 Feb; 557(1):19-27. PubMed ID: 25479009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.